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Highlights 
 Applying cluster analysis, Lysaker et al. (2004), identified different subgroups of 
schizophrenia patients with and without OCS, those with relatively high social functioning 
and those with relatively low social functioning. The current study is a replication 
approach in a large representative cohort of patients with psychotic disorder with cross-
sectional and longitudinal assessments.   
 Similar to the study of Lysaker et al. (2004) cluster analysis formed subgroups differing in 
the presence of OCS and social functioning. In the current study the following five clusters 
were identified: an OCSneg/HF (no OCS/ high functioning) group, an OCSneg/PF (no 
OCS/poor functioning) group, an OCSmild/HF (mild-OCS/ high functioning) group, an 
OCSmild/PF (mild-OCS/ poor functioning) group and an OCShigh/MF (high-OCS/ moderate 
functioning) group.  
 In line with the study of Lysaker et al. (2004), the OCSmild/HF group showed less negative 
symptoms than the poor functioning groups. However, in contrast to the original study, 
the group with OCS and poor functioning did not differ in executive functioning or 
sustained attention compared to the other groups. 
 Results support the idea that co-morbid OCS can have different implications for different 
subgroups of patients. 
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Abstract 
 
Research has found that Obsessive Compulsive Symptoms (OCS) in schizophrenia are associated 
with either more or less negative symptoms and either better or poorer cognitive functioning.  In 
order to explain these contradictory results, Lysaker et al.(Lysaker et al., 2004), performed a 
cluster analysis resulting in 2 OCS positive (OCSpos) clusters, one with higher functioning (HF) and 
one with poorer functioning (PF) compared to 2 OCS negative (OCSneg) clusters. The OCSpos/HF 
cluster had less negative symptoms compared to all other clusters, while the OCSpos/PF cluster 
showed poorer executive functioning. We performed a replication study, in an almost 10 times 
larger, representative sample, using both a longitudinal and cross-sectional design. Similar to 
Lysaker et al., we found a group with mild OCS and HF (OCSmild/HF) showing less negative 
symptoms compared to the PF groups.  We also found an OCSmild/PF group, which did not 
significantly differ in executive functioning from the other groups. Moreover, we did not find 
evidence for a better prognosis in the OCSmild/HF group, and thus found no support for the 
assumption that for some patients OCS might be an effective coping mechanism. 
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1. Introduction 
The co-occurrence of obsessive compulsive symptoms (OCS) and obsessive compulsive disorder 
(OCD) in schizophrenia has been studied extensively over the past three decades. Until the 1980’s 
OCD was believed to be a rare condition in schizophrenia with incidence rates varying from 1.1% 
to 3.5% in studies of clinical records (Rosen, 1957). Jahrreiß and Rosen concluded that patients 
with schizophrenia and comorbid OCD “tended to have a comparatively benign clinical course and 
better outcome” (Hwang et al., 2006). Recently, a meta-analyses found a mean OCD prevalence 
of 12.3% in patients with schizophrenia. Obsessive-compulsive symptoms (OCS) were reported in 
30.7% of cases (Swets et al., 2014). Moreover, contrary to what Jahrreiß and Rosen concluded, 
many studies found that comorbid OCD in schizophrenia patients was associaded with poorer 
social functioning (de Haan et al., 2012; Fenton and McGlashan, 1986), more severe positive and 
negative symptoms and lower global functioning (Berman et al., 1998; Cunill et al., 2009; Hwang 
et al., 2000; Lysaker et al., 2000; Schirmbeck et al., 2016b). However, some studies found less 
severe negative symptoms in patients with comorbid OCS (Tibbo et al., 2000), lower levels of 
positive and negative symptoms in patients with a first psychotic episode and comorbid OCS (de 
Haan et al., 2005; Poyurovsky et al., 1999) or less formal thought disorders (Bleich-Cohen et al., 
2014), while others found no significant association between OCS and other symptoms (de Haan 
et al., 2012; Faragian et al., 2009; Nasrollahi et al., 2012; Poyurovsky et al., 2006). Inconsistent 
findings have also been reported regarding assoiations between comorbid OCS and cognitive 
functioning in patients with psychotic disorders (Meijer et al., 2013; Schirmbeck et al., 2016a) 
and in the at risk mental state (Zink et al., 2014). In an attempt to explain these discripancies in 
clinical findings, several authors postulated that patients with schizophrenia and OCS might 
represent distinct subgroups (de Haan and Zink, 2015; Schirmbeck et al., 2015). Whereas some 
authors proposed subgroups according to differences in neurobiological features or antipsychotic 
treatment (Schirmbeck and Zink, 2013), Lysaker et al. hypothesized two distinct groups in 
patients with schizophrenia and comorbid OCS based the phenomenological level, one associated 
with poorer functioning and worse outcome, the other with better functioning and better 
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outcome (Lysaker et al., 2004). Identification of these subgroups would partially explain the 
heterogenity in outcome and would give support to earlier findings that OCS is associated with a 
benign course in some individuals. Lysaker and colleagues performed a cluster analysis using the 
Yale Brown Obsessive and Compulsive Scale (Y-BOCS; (Goodman et al., 1989)) to asses OCS and 
the Quality of Life Scale (QoL) (Heinrichs et al., 1984), to assess psycho-social functioning. Cluster  
analysis assigns patients to a group in such a way that patients in the same group (called a cluster) 
are more similar to each other than the patients in the other clusters. Lysaker et al. analysed 
different cluster solutions and identified 4 cluster as the optimal solution. This solution consisted 
of a poor functioning (PF) and a high functioning (HF)  group with OCS (OCSpos) and a PF and a HF 
group without OCS (OCSneg). The OCSpos/HF group had less severe negative symptoms than all 
the other groups, whereas the OCSpos/PF group showed poorer attention and executive 
functioning compared to the other groups. Positive symptoms did not differ significantly between 
the groups. From this study it appeared that OCS was associated with better functioning in some 
individuals and with poorer functining in others when compared to the OCSneg groups. These 
different subgroups might have clinical implications as to how co-morbid OCS in schizophrenia 
should be interpreted and treated. However, the study sample of Lysaker et al. was small, with a 
total sample of 66 patients, and groups consisting of 9-25 individuals. Hence, findings of this 
study need replication in a larger sample. The Genetic Risk and Outcome of Psychosis (GROUP) 
study sample is a large representative cohort of patients with non-affective psychotic disorders, 
who have been extensivly investigated regarding different aspects of functioning and 
psychopathology, both cross-sectionally and longitudinally.  
In this paper we aim to replicate the cluster analyses of Lysaker et al. (2004), in the large GROUP 
sample, using both a cross-sectional and longitudinal design. Similar to Lysaker et al., we expect 
to distinguish four subgroups of patients with schizophrenia and comorbid OCS: one with good 
social functioning and one with poor social functioning and comparable subgroups in patients with 
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schizophrenia without OCS using cluster analysis. In line with their findings, our primary 
hypotheses are a) that patients in the OCSpos/PF group will show poorer executive functioning 
and sustained attention and more negative symptoms than any other group and b) that patients in 
the OCSpos/HF group will show lower levels of negative symptoms compared to the poor 
functioning groups. Furthermore,  in a longitudinal approach we will evaluate whether proposed 
differences in cognitive domains and negative symptoms between clusters, will remain present at 
3 year follow-up. As Lysaker et al. (2004) suggested in their discussion: “research employing 
longitudinal assessments of the fate of patients with and without OCS symptoms will shed more 
light on the question if subgroups exist”.  Stability of outcome will favour this hypothesis. More 
specifically, we will test the hypothesis c) that differences in negative symptoms and cognitive 
functioning between the four subgroups at baseline remain stable at 3-year follow-up. 
 
2. Methods 
 
2.1. Study design and participants 
The study sample was part of the multicenter GROUP study. The procedure of recruitment and 
population characteristics have been described in detail elsewhere (Korver et al., 2012). In short, 
inclusion criteria for patients were (1) age range of 16 to 50 years and (2) good command of the 
Dutch language. Patients had to meet DSM-IV-TR criteria for a non-affective psychotic disorder 
(APA, 2000) which was assessed with the Comprehensive Assessment of Symptoms and History 
(CASH (Andreasen NC, 1992)) or the Schedules for Clinical Assessment for Neuropsychiatry version 
2.1 (SCAN (Wing JK, 1990)). GROUP participants were included in a post-acute phase, when they 
were willing and able to take part in assessments lasting on average four hours. All participants 
provided written informed consent prior to their inclusion in the study, which was approved by 
the accredited Medical Ethics Review Committee (METC). Patients with complete data on the Y-
BOCS and the Social Functioning Scale (SFS) (n=655) were included in the current study.  
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2.2. Clinical Measures 
Sociodemographic and clinical data on age, gender, education level, duration of illness, IQ 
estimation (Korver et al., 2012) and medical treatment were included in the current study.  
Severity of OCS was measured with the Y-BOCS (Goodman et al., 1989). The Dutch translation of 
the YBOCS has been validated for the assessment of OCS in schizophrenia (Boyette et al., 2011; 
de Haan et al., 2006). The Y-BOCS assesses different aspects (time, handicap, frequency, 
controllability, and discomfort) of obsessions compulsions on 5-point Likert-scales, resulting in 
two subscales and a total score. Severity of positive, negative symptoms and general 
psychopathology was assessed with the Positive and Negative Syndrome Scale (PANSS) according 
to the three-factor model (Kay et al., 1987). The PANSS has been translated into Dutch by 
Linszen, de Haan, Kuipers and Dingemans, AMC department of psychiatry (1995). 
In accordance to Lysaker et al. (2004) the two cognitive domains of executive functioing and 
sustained attention were investigated (Lysaker et al., 2004). Impairment in executive functioning 
and flexibility in thought was assessed with the Response shifting task (RST) a modified version of 
the Competing Programs Task (Nolan et al., 2004).  Sustained attention was measured with the 
Continuous Performance Test (CPT) (Nuechterlein and Dawson, 1984). For both tasks, assessment 
was computerized using E‐prime 1.3 (Psychology Software Tools, Inc., Pittsburgh, PA, 2001). In 
addition to tasks assessing executive functioing and sustained attention we also included the 
Digit-Symbol Coding test (DSC), a subset of the Wechsler Adult Intelligence Scale-Third Edition 
(WAIS-III (Wechsler, 1997)) measuring processing speed in a visual perception and memory task. 
The Dutch translation of the WAIS-III has been validated by van der Heijden (2013)(van der 
Heijden et al., 2013). Performance in this task has been found associated with co-occurring OCS 
in previous studies (Meijer et al., 2012; Schirmbeck et al., 2016a). 
The SFS (Birchwood et al., 1990) was used to assess social functioning over the past 3 months. 
The scale was translated into Dutch by de Boer et al. (2002) in agreement with the original 
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authors. The SFS has been widely used to measure areas of functioning essential for successful 
community maintenance, containing 7 subscales: withdrawal, interpersonal behavior, prosocial 
activities, recreation, independence-performance, independence-competence, and 
employment/occupation. The SFS has shown to be a reliable and valid measure in both patients 
with psychotic disorders and the general population (Birchwood et al., 1990). Higher scores on 
the SFS indicate higher levels of social functioning. We used the overall score in the analyses. 
The Global Assessment of Functioning-symptoms (GAF S) (Jones et al., 1995) was used to assess 
the severity of symptoms in combination with functioning. The GAF is a widely used assessment 
instrument with scores ranging from 0 to 100, with higher scores corresponding with less 
symptoms. The Dutch version of the GAF is part of the DSM-IV-TR (APA, 2000) and has been 
validated in Dutch patients (Havenaar et al., 2004). 
 
2.3. Statistical analysis 
We performed Statistical analyses using the Statistical package for Social Sciences (SPSS version 
24.0, Chicago, IL, US). According to Lysaker et al (2004), cluster analysis was based on 
assessment instruments measuring OCS and social functioning. Therefore, Y-BOCS and SFS scores 
were transformed to z-scores. Average between group linkage hierarchical cluster analysis was 
used to determine the optimal number of clusters, using the squared Euclidian distance. An 
optimal number of clusters is reached when as few as possible clusters with an minimum distance 
to the mean is identified. The number of clusters before a jump in coefficient values is generally 
considered as the optimal (Yim, 2015). Subsequently we performed K-Means cluster analyses to 
determine the Y-BOCS and SFS scores of the clusters, the patient subgroups. After the clusters 
were defined, Pearson Chi-Square tests and t-tests were used when appropriate, in order to 
determine demographic, illness characteristics and prevalence of the different clusters. Analyses 
of covariance (ANCOVA) was used to compare the identified clusters on psychopathology as 
measured with the PANSS and cognitive domains as measured with the RST accuracy scores, the 
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CPT omission and commission scores and the DSC task, corrected for significant covariates and 
using Bonferroni correction. Release 5.0 of the GROUP database was used for the analyses. 
 
3. Results 
Hierarchical cluster analyses were performed (n=655) to investigate if we can replicate the 
proposed four subgroups of patients with schizophrenia and comorbid OCS: one with good social 
functioning and one with poor social functioning, and comparable subgroups in patients with 
schizophrenia without OCS. Following Lysaker et al. (2004), we focused on the optimal solution 
looking at 2-6 possible clusters, and identified the 4 cluster solution as optimal after examination 
of the Euclidian squared distances between the clusters. However, this 4 cluster solution yielded 
3 OCSpos groups and only one OCSneg group, making good comparison with the groups identified 
by Lysaker et al.(2004) impossible.  The 5 cluster solution (with a faily similar squared Euclidian 
distance) resulted in comparable subgroups with high and poor functioning in both groups with 
and without co-morbid OCS, hence we decided to use the 5 cluster solution.   
Table 1 shows mean SFS and Y-BOCS scores, demographic characteristics and clinical variables of 
the 5 clusters. Cluster n=276 participants with OCSneg/HF (no-OCS and high functioning), cluster 
2 n=52 participants with OCSmild/HF (mild OCS and high functioning), cluster 3 n=36 participants 
with OCShigh/MF (high OCS and moderate functioning), cluster 4 n=241 participants with 
OCSneg/PF (no-OCS and poor functioning), cluster 5 n=50 participants with OCSmild/PF (mild OCS 
and poor functioning). Gender, IQ and clozapine use differed significantly between groups and 
were added as covariates in subsequent group comparisons.  
To evaluate the proposed differences in cognitive domains and negative symptoms between the 
subgroups, analyses of covariance were performed. Cross-sectionally,  ANCOVA revealed 
significant differences between groups on DSC scores and CPT omission scores. Groups did neither 
significantly differ on RST accuracy scores nor on CPT commision scores. Pairwise comparison did 
not reveal significant differences on CPT omission scores. Regarding the DSC, the only significant 
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group differences were found for better performance of the OCSneg/HF group compared to the 
two poor functioing groups (see table 2).   
Regarding negative symptom severity, analysis revealed a significant overall group effect. 
Subsequent pairwise comparisions showed that the OCSmild/HF group had significantly lower 
scores compared to the two PF groups. Compared to the other two groups there was no 
significant difference in PANSS-negative scores. The OCSmild/PF did not differ from the 
OCSneg/PF, but showed lower scores than the two HF groups. In addition, the OCSneg/HF group 
showed less positive and general symptoms compared to all other groups and the OCShigh/MF 
group showed higher positive and general symtpoms compared to all other groups, except for the 
OCSmild/PF group (see table 2).  When including covariate in the analyses, the results did not 
significantly change. Because of the known association between clozapine treatment and OCS, we 
conducted additional group-comparisons in the subset of patients without clozapine treatment. 
Results of this sensitivity analyses did not significantly differ from whole sample analyses. 
Subsequently, in an explorative approach, we evaluated whether differences in the level of 
negative symptoms remained stable over the 3-year follow-up period. Patients with complete 
data on the PANSS negative symptoms subscale at both assessments (n=503) were included in this 
analyses. Of the original sample 152 patients could not be included because of missing data. 
Cluster analyses, using baseline data, were repeated with this substantially smaller sample and 
resulted in highly comparable clusters to those identified using the initial dataset of n=655.  As a 
result of the substantial smaller sample with complete data at 3 year follow-up, the OCShigh/MF 
cluster consisted of a relatively small number of cases (n=21). For reasons of completeness we 
included this group in our analyses, but readers should be aware that because of this small 
sample size results of the OCShigh/MF cluster should be interpreted with caution (see table 1 
supplementary material). Figure 1 shows the mean PANSS negative scores per cluster at baseline 
and follow-up. Correcting the analyses for gender, IQ and clozapine use did not change those 
result significantly. The uncorrected results are shown. At follow-up, significanly lower negative 
symptom severity of the  OCSmild/HF group compared to the two PF groups at baseline were no 
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longer apparent. The OCSmild/PF group only showed remaining significantly higher PANSS 
negative scores compared to the OCSneg/HF group.  
Comparing PANSS negative scores at baseline and follow-up per cluster, both HF groups showed 
significant higher scores at follow up (OCSneg/HF: difference between means= -0,59, SD= 3,59, 
p=0,016 OCSmild/HF group: difference between means=-1,61, SD= 4,03, p=0,013). The 
OCSmild/PF group showed significantly lower scores at follow up (difference between means= 
1,74, SD= 4,05, p=0,018). However, results did not withstand Bonferroni correction.  
 
4. Discussion  
4.1. General discussion 
The aim of the current study was to replicate findings of a cluster analyses conducted by Lysaker 
et al. (2004) based on measures of OCS and social functioning, which resulted in different 
OCS/schizophrenia groups. Furthermore we aimed to repeat comparisons between these groups 
on executive functioning, sustained attention and negative symptom severity.  It should be 
acknowledged that due to the fact that GROUP was not specifically designed as a replication 
study, observed differences in results might partly be explained by differences in assessment 
instruments (see elaborated discussion below). Our results partly support Lysaker’s findings. By 
using the same cluster analysis as Lysaker et al. (2004) we also found the 4 cluster solution to be 
optimal. Unfortunately, this solution did not yield the proposed 4 groups differing in functioning 
and OCS status. Therefore, we used the 5-cluster solution, which resulted in more comparable 
groups to the study by Lysaker et al. (2004): a OCSneg/PF, OCSneg/HF,  OCSmild/PF and 
OCSmild/HF groups and a fifth group, with high Y-BOCS scores and moderate functioning. In 
contrast to the original study, mean OCS symptom severity in our sample was considerably lower. 
Whereas in the sample of Lysaker et al. 32% of patients reported OCS with a Y-BOCS score of 20, 
only 21% of the current sample reported OCS with a mean score of 12. Nevertheless, similar to 
Lysaker et al. (2004), we were able to distinguish two different groups of patients with a 
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psychotic disorder and comorbid OCS – one with mild OCS and relatively good social functioning 
and one with mild OCS and relatively poor social functioning. Besides differences in sample 
characteristics, differences in the assessment of social functioning might have affected the 
results of the cluster analyses. Lysaker et al. used the QoL to assess psychosocial functioning, 
whereas the SFS was used in GROUP. Although both instruments measure comparable aspects of 
social functioning (e.g. interpersonal relations, vocational functioning/occupation, common 
activities/recreation) (Birchwood et al., 1990; Heinrichs et al., 1984), the QoL focusses more on 
subjective wellbeing, whereas the SFS focusses more on objective well-being. We are not aware 
of a study directly comparing both instruments, to estimate the potential difference in results.  
Regarding comparisons between groups on executive functioning and sustained attention, 
contrary to our hypothesis we did not find significant groups differences. Hence, we could not 
replicate poorer performance of the OCS/PF group compared to the other groups reported by 
Lysaker et al. (2004). The addition of the task measuring processing speed, only resulted in lower 
scores of OCSmild/PF group compared to the OCSneg/HF group. Again, it has to be noted, that 
observed differences with results reported by Lysaker et al., (2004) might be due to differences 
in applied assessment instruments.  Unfortunately, the Wiscounsin Card Sorting Test, used by 
Lysaker et al. (2004) was not included in the GROUP-assessment battery. Executive functioning, 
more specifically cognitive flexibility was measured with the  Response Shifting Task in the 
current study.  
In line with our second hypothesis group-comparisons on negative symptom severity revealed that 
the OCSmild/HF group showed less severe negative symptoms than the two poor functioning 
groups (the OCSmild/PF and the OCSneg/PF). The OCSmild/PF showed more negative symptoms 
compared to the two high functioning group. Therefore, in accordance with Lysaker et al. (2004) 
we found evidence for a subgroup with OCS, high functioning and less severe negative symptoms.  
In an explorative approach we subsequently investigated whether observed differences in 
negative symptom severity remained stable over a 3-year period. Results showed that the 
OCSmild/PF group only showed remaining higher negative symptom severity compared to the 
OCSneg/HF group, while significant differences between the OCSmild/HF group and the two PF 
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groups were lost at follow-up. These results do not support the hypothesis that the OCSmild/HF 
group would show a milder course of illness, expressed by a consistent low score of negative 
symptom severity at follow-up or any other symptom domains. Hence we did not find evidence 
for the proposed possibility by Lysaker et al. (2004) that the presence of a group with OCS and 
better functioning, despite equivalent levels of neurocognitive function might suggest that OCS 
“have some protective function for persons with schizophrenia who do not have severe 
neurocognitive deficits”. Since the study of Lysaker et al. (2004) has been published, an 
increasing number of studies has investigated the association between the presence of comorbid 
OCS and functioning. Several findings have suggested a possible dual impact of OCS on 
functioning, with mild OCS being associated with better functioning and severe OCS with poorer 
functioning (de Haan et al., 2013; Tonna et al., 2016a, b). However, Kontis et al., (2016) found a 
positive association between OCS and social functioning, independent of cognitive functioning 
and the severity of OCS (Kontis et al., 2016). Other recent studies indicated a negative 
association with social and vocational functioning, even with relatively mild OCS severity 
(Schirmbeck et al., 2016b) or no associations (Grover et al., 2017). In line with these inconsistent 
findings, our cluster analyses results in two groups with mild OCS severity, one with relatively 
good social functioning and one with relatively poor social functioning. Furthermore, the group 
with high OCS severity showed moderate function. Hence, we cannot draw general conclusions on 
the association between the presence of comorbid OCS severity and implications on social 
functioning, associated clinical impairment or implications for the prospective course. Both 
cluster analyses suggest that different subgroups of comorbid patients exists, those with high and 
those with lower social functioning. Apart from associations with negative symptoms, future 
studies should further investigate possible underlying factors, including a more comprehensive 
assessment of different cognitive domains, dosage of antipsychotic treatment, environmental 
factors (e.g. social support) and patient characteristics (e.g. coping strategies). More prospective 
studies are needed to investigate stability of these clusters and the course of associated 
variables, particularly as recent findings suggest significant fluctuation and covariation in OCS 
severity and symptoms of psychosis over time (Schirmbeck et al., 2018)  
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4.2. Strengths and limitations 
The GROUP cohort is a large cohort representing the general patient population with non-
affective psychotic disorders and has been assessed with a comprehensive test-battery, including 
OCS, cognitive functioning and social functioning. Although not specifically designed to replicate 
the study by Lysaker et al. (2004), GROUP offered the great opportunity to perform a replication 
approach following most of the original design in a large sample with cross-sectional and 
longitudinal assessments. With a sample size of 655, we achieved enough power (1-β=.80) to 
detect effect sizes as small as f=0.15. Compared to the study by Lysaker et al., (n=66), we would 
have been able to detect much smaller effects. Therefore, negative results in our study are not 
likely explained by a type II error. The large sample improves generalizability to the patient 
population with psychotic disorders. Replication of scientific results is essential. Too few 
replication studies are performed, while this is a crucial step in the evaluation of scientific 
results, providing information on stability and generalizability of its conclusions. The longitudinal 
design of GROUP allowed us to evaluate stability of results after 3-years. However, several 
limitations should be noted. Differences in patient sample and applied instruments between the 
current study and Lysaker et al. (2004), addressed earlier, may account for differences in result. 
In comparison to the sample investigated by Lysaker et al. (2004), the current sample showed 
less severe OCS, positive and negative symptoms and consisted of much younger participants and 
included females. Furthermore, no reliable information was available on dosage of antipsychotic 
treatment. We tried to account for the assumed pro-obsessive effect of particularly clozapine by 
including a sensitivity analyses, excluding all patients with clozapine treatment. 
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4.3. Summary 
This study is a replication study of a cluster analyses conducted by Lysaker et al. (2004) in a large 
representative sample of patients with psychotic disorders. The orinigal study found four 
subgroups of patients with schizophrenia according to the presence of comorbid OCS and the 
level of social functioning (Lysaker et al., 2004). When chosing a 5-cluster solution the current 
study identified similar subgroups, including a group with OCS and relatively poor social 
functioning and a group with OCS and relatively high social functioning. In line with Lysaker et 
al., the group with OCS and high functioning showed less negative symptoms compared to the 
groups with poor functioning. However, these differences did not persist at 3-year follow-up. 
Furthermore, although the large sample provided sufficient statistical power we were not able to 
replicate that the group with OCS and poorer social functioning showed higher deficits in 
executive functioning or sustained attention compared to the other groups. Taken together, our 
results support the assumption that co-morbid OCS can have different implications for different 
subgroups of patients with psychotic disorders. In some patients OCS seem to be associated with  
less severe other problems. However, we did not find evidence for a benificial course of illness in 
this group. Future prospective studies are needed to investigate stability of proposed clusters and 
apply broader assessment of associated clinical variables. 
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Figure 1 shows the mean PANSS negative scores per cluster at baseline and follow-up. 
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Table 1 
Demografic 
variables 
(mean) 
Cluster 1 
OCSneg/HF 
(n=276) 
Cluster 2 
OCSmild/HF 
(n=52) 
Cluster 3 
OCShigh/MF 
(n=36) 
Cluster 4 
OCSneg/PF 
(n=241) 
Cluster 5 
OCSmild/PF 
(n=50) 
F, df P< 
Y-BOCS Totala 0.1 ± 0.4 8.0 ± 2.2 19.8 ± 4.3 0.1 ± 0.5 10.0 ± 3.0 F4,654  
= 
2042.2 
0.0005 
SFS Totalb 120.6 ± 4.8 116.5 ± 5.1 108.5 ± 8.8 105.1 ± 
6.2 
102.2 ± 6.2 F4,654 = 
290.8 
0.0005 
Age 27.2 ± 7.2 26.6 ± 6.2 27.1 ± 6.3 27.9 ± 8.0 27.1 ±6.1 F4,654 
=0.5 
NS 
Male% 69.9 73.1 83.8 82.2 80.0 Χ24, 
659 = 
12.7 
0.013 
Education% Χ28, 
655 = 
34.9 
0.001 
Primary school 5.4 13.3 19.4 14.9 14.0   
Secondary 
school 
57.6 63.5 58.3 66.0 70.0   
 Higher 
education 
37.0 23.1 22.2 19.1 16.0   
IQ 102.4 ± 
15.8 
95.8 ± 13.8 98.1 ± 19.0 96.2 ± 16.9 94.0 ± 
14.6 
F4,484 
= 4.9 
0.001 
Duration of 
illness(years) 
7.4 ± 3.7 8.0 ± 4.1 8.1 ± 3.8 7.7 ± 4.8 8.0 ± 4.1 F4,621 
= 0.4 
NS 
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Table 1: Shows mean SFS and Y-BOCS scores and the demographic characteristics of the 5 clusters. 
Abbreviations: IQ: Intelligence quotient, OCSneg/HF (no-OCS and high functioning), OCSmild/HF (mild 
OCS and high functioning), OCShigh/MF (high OCS and moderate functioning), OCSneg/PF (no-OCS and 
poor functioning), OCSmild/PF (mild OCS and poor functioning), NS: not significant, SFS: Social 
Functioning Scale, Y-BOCS: Yale Brown Obsessive Compulsive Scale   
Clozapine use % 
using 
7.5 28.8 45.9 22.8 22.0 Χ24, 
659 = 
48.7 
0.0005 
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Table 2: Shows the mean scores and group-differences on the PANSS subscales and investigated 
cognitive domains at baseline 
 
 
Results at 
baseline 
Cluster 1 
OCSneg/HF 
(n=276) 
Cluster 2 
OCSmild/HF 
(n=52) 
Cluster 3 
OCShigh/MF 
(n=36) 
Cluster 4 
OCSneg/PF 
(n=241) 
Cluster 5 
OCSmild/PF 
(n=50) 
F, df P< 
Y-BOCS Totala 0.1 ± 0.4 8.0 ± 2.2 19.8 ± 4.3 0.1 ± 0.5 10.0 ± 3.0 F4,654  = 
2042.2 
0.0005 
SFS Totalb 120.6 ± 4.8 116.5 ± 5.1 108.5 ± 8.8 105.1 ± 
6.2 
102.2 ± 6.2 F4,654 = 
290.8 
0.0005 
GAF Sc 68.6 ± 14.3 57.2 ± 12.7 50.8 ± 16.4 56.9 ± 
13.5 
47.5 ± 15.3 F4,556 = 
36.8 
0.0005 
PANSS scales        
Positived 9.2 ± 3.4 12.0  ± 3.7 14.7 ± 5.1 11.6 ± 4.8 13.4 ± 4.7 F4,645 = 
25.9 
0.0005 
Negativee 9.3 ± 3.1 11.0 ± 3.5 13.4 ± 4.5 14.1 ± 5.6 14.6  ± 6.1 F4,645 = 
42.1 
0.0005 
Generalf 20.5 ± 5.3 24.8 ± 5.2 30.5 ± 7.4 25.6 ± 7.0 28.9 ± 7.3 F4,645 = 
42.5 
0.0005 
Cognitive 
scales 
       
Digital symbol 
Codingg 
9.1 ± 3.3 7.8 ± 3.0 7.8 ± 2.9 7.4 ± 2.7 7.1 ± 2.2 F4,488 = 
8.9 
0.0005 
RST accuracy 0.19 ± 0.26 0.15 ± 0.27 0.26 ± 0.33 0.19 ± 
0.27 
0.17 ± 0.22 F4,621 = 
1.0 
NS 
CPT omissionsh 0.96 ± 1.8 1.21 ± 1.7  2.13 ± 3.0 1.45 ± 2.5 1.77 ± 2.8 F4,691 = 
3.3 
0.011 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
CPT 
commisions 
1.64 ± 10.0 1.50 ± 4.6 1.53 ± 2.5 2.15 ± 9.7 1.29 ± 3.1 F4,591 = 
0.2 
NS 
 
Abbreviation: CPT: Continuous Performance Test, GAF: General Assessment of Functioning Scale, 
OCSneg/HF (no-OCS and high functioning), OCSmild/HF (mild OCS and high functioning), OCShigh/MF 
(high OCS and moderate functioning), OCSneg/PF (no-OCS and poor functioning), OCSmild/PF (mild OCS 
and poor functioning), PANSS: Positive and Negative Syndrome Scale, NS: not significant, RST: Response 
Shift Task, SFS: Social Functioning Scale, Y-BOCS: Yale Brown Obsessive Compulsive Scale 
aCluster 3 > cluster 5 > Cluster 2 > ,cluster 1,cluster 4,  P < 0.0005 
bCluster 1 > Cluster 2 > Cluster 3 > Cluster 4,  P < 0.0005;  Cluster 3 > cluster 4, P=0.010; Cluster 4 > 
Cluster5, P=0.011 
cCluster 1  > Cluster 2, 3, 4, 5, P < 0.0005; Cluster 2, 4 > Cluster 5, P < 0.05  
dCluster 2, 3, 4, 5  > Cluster 1, P < 0.0005; Cluster 3> Cluster 4, P < 0.0005; Cluster 3 > Cluster 2,  P = 
0.023  
eCluster 4, 5 > Cluster 1, 2,  P < 0.001; Cluster 3 > Cluster 1,  P < 0.0005 
fCluster 3 > Cluster 1, 2, 4, P < 0.0005; Cluster 5> cluster1, P < 0.0005; Cluster 5 > Cluster 4, P = 0.010; 
Cluster 5 > Cluster 2, P=0.011;  Cluster 2, 4 > Cluster 1, P <  0.0005 
gCluster 1  > Cluster 4, 5,  P < 0.001 
hCluster 3  > Cluster 1,  P = 0.066 
 
